Results 81 to 90 of about 354 (138)

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study. [PDF]

J Clin Oncol
Medina T, Chesney JA, Kluger HM, Hamid O, Whitman ED, Cusnir M, Thomas SS, Wermke M, Domingo-Musibay E, Phan GQ, Kirkwood JM, Larkin J, Weber J, Graf Finckenstein F, Chou J, Gastman B, Wu X, Fiaz R, Sarnaik AA, C-144-01 Investigators.   +19 more
europepmc   +1 more source

iNOS is a key mediator of anti-PD-1 melanoma therapy response. [PDF]

Front Immunol
Nguyen QT, Kim Y, Le THN, Garg S, Balkaran V, Bhathivi T, Chamizo A, Dukes CW, Ward K, Brohl AS, Karapetyan L, Khushalani NI, Eroglu Z, Tarhini AA, Mulé JJ, Markowitz J.   +15 more
europepmc   +1 more source

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma. [PDF]

J Immunother Cancer
Tarhini AA, Khaksar MA, Chen Z, Lee SJ, Stephen Hodi F, Li T, Yoder SJ, Streicher H, Sondak VK, Kirkwood JM, Wang X, Kanetsky PA.   +11 more
europepmc   +1 more source

Six Newly Sequenced Chloroplast Genomes From Quadriflagellate Chlamydomonadales (Chlorophyceae): Phylogeny and Comparative Genome Analyses. [PDF]

Genome Biol Evol
Chen Y, Xiong Q, Dai Q, Liu G.
europepmc   +1 more source

Specific oncogene activation of the cell of origin in mucosal melanoma. [PDF]

Nat Commun
Babu S, Chen J, Baron CS, Sun K, Robitschek E, McConnell AM, Wu C, Dedeilia A, Sade-Feldman M, Modhurima R, Manos MP, Chen KY, Cox AM, Ludwig CG, Kellis M, Buchbinder EI, Hacohen N, Yang J, Boland GM, Abraham BJ, Liu D, Zon LI, Insco ML.   +22 more
europepmc   +1 more source

Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma. [PDF]

Sci Adv
Tarantino G, Ricker CA, Wang A, Ge W, Aprati TJ, Huang AY, Madha S, Chen J, Shi Y, Glettig M, Feng CH, Frederick DT, Freeman S, Holovatska MM, Manos MP, Zimmer L, Rösch A, Zaremba A, Livingstone E, Jameson JC, Saghafian S, Lee A, Zhao K, Morris LGT, Reardon B, Park J, Elmarakeby HA, Schilling B, Giobbie-Hurder A, Vokes NI, Buchbinder EI, Flaherty KT, Haq R, Wu CJ, Boland GM, Hodi FS, Van Allen EM, Schadendorf D, Liu D.   +38 more
europepmc   +1 more source

Local immunotherapy for the treatment of cancer: scientific advances and clinical potential. [PDF]

J Immunother Cancer
Kaufman HL, de Gruijl TD.
europepmc   +1 more source

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer. [PDF]

Gynecol Oncol
Gaillard S, Verma N, Berg M, Harrison J, Huang P, Leatherman JM, Doucet M, Sen R, Suru A, Cai H, Durham J, Jelovac D, Cimino-Mathews A, Cherry C, Ganguly S, Emens LA.   +15 more
europepmc   +1 more source

Facts and Hopes: Toward the Next Quantum Leap in Melanoma. [PDF]

Clin Cancer Res
Flaherty KT, Aplin AE, Davies MA, Hacohen N, Herlyn M, Hoon D, Hwu P, Lotem M, Mulé J, Wargo JA, Fisher DE.   +10 more
europepmc   +1 more source

Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma. [PDF]

Mol Cancer Ther
Henrich IC, Billingsley MM, Jain K, Mondal S, Quick LN, Quick LN, Young R, Nguyen N, Nguyen N, Oliveira AM, Blobel GA, Mitchell MJ, Chou MM.   +12 more
europepmc   +1 more source